Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation
- 26 October 1998
- journal article
- withdrawal
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 4,p. CD001320
- https://doi.org/10.1002/14651858.cd001320.pub2
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Prevention of cytomegalovirus disease in transplant recipientsThe Lancet, 1995
- EFFICACY OF A 6-WEEK PROPHYLACTIC GANCICLOVIR REGIMEN AND THE ROLE OF SERIAL CYTOMEGALOVIRUS ANTIBODY TESTING IN LUNG TRANSPLANT RECIPIENTSTransplantation, 1995
- High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantationTransplant International, 1995
- A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2Transplantation, 1994
- VIRAL PROPHYLAXIS IN COMBINED PANCREAS-KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1994
- Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adultsJournal of Medical Virology, 1993
- REDUCTION BY COMBINATION PROPHYLACTIC THERAPY WITH CMV HYPERIMMUNE GLOBULIN AND ACYCLOVIR OF THE RISK OF PRIMARY CMV DISEASE IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1993
- Solid organ transplantation: Results and implications of acyclovir use in liver transplantsJournal of Medical Virology, 1993
- Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case-controlled studyJournal of Medical Virology, 1993
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989